Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples

ABSTRACT: DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples

PROVIDER: PRJNA734326 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14702918_1.fastq.gz	Fastqsanger.gz
	SRR14702918_2.fastq.gz	Fastqsanger.gz
	SRR14702919_1.fastq.gz	Fastqsanger.gz
	SRR14702919_2.fastq.gz	Fastqsanger.gz
	SRR14702920_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 46

Similar Datasets

DeMixSC: a deconvolution framework that uses single-cell sequencing plus a small benchmark dataset for improved analysis of cell-type ratios in complex tissue samples

Project description:Bulk deconvolution with single-cell/nucleus RNA-seq data is critical for understanding heterogeneity in complex biological samples, yet the technological discrepancy across sequencing platforms limits deconvolution accuracy. To address this, we introduce an experimental design to match inter-platform biological signals, hence revealing the technological discrepancy, and then develop a deconvolution framework called DeMixSC using the better-matched, i.e., benchmark, data. Built upon a novel weighted nonnegative least-squares framework, DeMixSC identifies and adjusts genes with high technological discrepancy and aligns the benchmark data with large patient cohorts of matched-tissue-type for large-scale deconvolution. Our results using a benchmark dataset of healthy retinas suggest much-improved deconvolution accuracy. Further analysis of a cohort of 453 patients with age-related macular degeneration supports the broad applicability of DeMixSC. Our findings reveal the impact of technological discrepancy on deconvolution performance and underscore the importance of a well-matched dataset to resolve this challenge. The developed DeMixSC framework is generally applicable for deconvolving large cohorts of disease tissues, and potentially cancer.

2023-11-13 | GSE175937 | GEO

A deconvolution framework that uses single-cell sequencing plus a small benchmark data set for accurate analysis of cell type ratios in complex tissue samples.

Project description:Bulk deconvolution with single-cell/nucleus RNA-seq data is critical for understanding heterogeneity in complex biological samples, yet the technological discrepancy across sequencing platforms limits deconvolution accuracy. To address this, we utilize an experimental design to match inter-platform biological signals, hence revealing the technological discrepancy, and then develop a deconvolution framework called DeMixSC using this well-matched, that is, benchmark, data. Built upon a novel weighted nonnegative least-squares framework, DeMixSC identifies and adjusts genes with high technological discrepancy and aligns the benchmark data with large patient cohorts of matched-tissue-type for large-scale deconvolution. Our results using two benchmark data sets of healthy retinas and ovarian cancer tissues suggest much-improved deconvolution accuracy. Leveraging tissue-specific benchmark data sets, we applied DeMixSC to a large cohort of 453 age-related macular degeneration patients and a cohort of 30 ovarian cancer patients with various responses to neoadjuvant chemotherapy. Only DeMixSC successfully unveiled biologically meaningful differences across patient groups, demonstrating its broad applicability in diverse real-world clinical scenarios. Our findings reveal the impact of technological discrepancy on deconvolution performance and underscore the importance of a well-matched data set to resolve this challenge. The developed DeMixSC framework is generally applicable for accurately deconvolving large cohorts of disease tissues, including cancers, when a well-matched benchmark data set is available.

| S-EPMC11789644 | biostudies-literature

MaxLFQ label-free quantification algorithm benchmark datasets

Project description:We developed a set of algorithms for label-free quantification, termed MaxLFQ, embedded into MaxQuant. This contains two datasets to benchmark MaxLFQ: The proteome benchmark dataset consists of of HeLa and E. coli lysates mixed at defined ratios. The dynamic range benchmark dataset consists of UPS1/UPS2 standards (Sigma) spiked into E. coli lysates and quantified against each other.

2014-09-17 | PXD000279 | Pride

Metagenome benchmark

Project description:Benchmark of metagenome analysis tools

| PRJEB8286 | ENA

Leveraging RNA-seq Deconvolution to Improve Complex In Vitro Model Characterization

Project description:Accelerating development of complex in vitro models (CIVMs) drives a need for additional methods to characterize these systems for use in toxicology and drug development. Relative to traditional cell culture, CIVMs may use a lower number of cells, are cultured for longer periods of time, and typically involve engineered 3-D cell organization. Standard single-cell assessment tools are not conducive to these types of complex models due to cell isolation stress, cell loss, and high cost. In this report, we benchmark RNA-seq deconvolution, which utilizes publicly available scRNA-seq datasets to predict cell proportions from bulk RNA-seq data derived from two CIVMs: a stem-cell-based human intestine epithelia model and a neonatal rodent testis model. We consider the impact of multiple imputation methods for scRNA-seq to restore the gene distribution of the original tissue to generate a better cell type signature and multiple deconvolution methods. The accuracy of deconvolution methods varied significantly in our analyses but provided valuable information on the emergence of an enterocyte cell population from the LGR5+ crypt stem cells following differentiation. In the testis model, deconvolution indicated that a small population of germ cells were retained over time, and that cell type estimates remained stable with physiologically relevant hormone stimulation. In our analysis, using imputed single cell references improved deconvolution accuracy. Deconvolution can be a useful tool for novel CIVM characterization, especially with rapidly growing libraries of single-cell data across tissues and developmental time.

2025-02-15 | GSE289712 | GEO

MaxLFQ label-free quantification algorithm benchmark datasets

2017-12-19 | MSV000081831 | MassIVE

Benchmark Data for scPLATE-Seq

Project description:Generate benchmark data for scPLATE-Seq

2021-11-11 | GSE104493 | GEO

Nanopore R10.4.1 Sequencing Benchmark Data

Project description:Nanopore R10.4.1 Sequencing Benchmark Data

| PRJEB64652 | ENA

Hartwig Medical Foundation Benchmark Set

Project description:Hartwig Medical Foundation Benchmark Set

| PRJEB33197 | ENA